Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ASLAN Pharmaceuticals Ltd (ASLN)
  7. News

ASLN

ASLAN Pharmaceuticals News

FREE ASLN REPORT

Company Name Stock Ticker Symbol Market Type
ASLAN Pharmaceuticals Ltd ASLN NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
0.0149 2.04% 0.7449 16:35:56
Open Price Low Price High Price Close Price Prev Close
0.7316 0.71 0.745 0.7449 0.73
more quote information »

Recent News

Date Time Source Heading
1/27/202311:59IHNWFeatured1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition
1/04/202306:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/21/202206:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
11/03/202216:08EDGARConfidential Treatment Order (ct Order)
11/03/202216:08EDGARConfidential Treatment Order (ct Order)
10/31/202206:15TRMNH.C. Wainwright Sticks to Their Buy Rating for Aslan..
10/28/202207:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/28/202209:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/15/202206:15TRMNH.C. Wainwright Remains a Buy on Aslan Pharmaceuticals..
9/13/202216:32EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
9/13/202216:06EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/08/202207:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
8/15/202206:25TRMNH.C. Wainwright Keeps Their Buy Rating on Aslan..
8/12/202206:55EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/23/202206:26TRMNAslan Pharmaceuticals (ASLN) Receives a Buy from H.C...
4/27/202207:00EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
4/21/202216:01EDGARStatement of Ownership (sc 13g)
4/01/202217:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/28/202206:26TRMNH.C. Wainwright Reaffirms Their Buy Rating on Aslan..
3/25/202207:54EDGARSecurities Registration: Employee Benefit Plan (s-8)
3/25/202207:30EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
3/25/202207:24SEEKASLAN Pharmaceuticals GAAP EPS of -$0.03
3/25/202207:06EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/15/202207:32SEEKAslan Pharmaceuticals appoints dermatology veteran Dr Alex..
3/15/202207:15EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/14/202208:53EDGARStatement of Ownership (sc 13g)